While the gold standard of HPV detection in head and neck cancers is now RNA-based detection of viral proteins E6/E7 (6), clinical and molecular analysis of p16 tumor data suggests that p16 may play an important role in the pathogenesis of head and neck cancers (7–10). This evidence concerns the gene CDKN2A and neoplasm.